Allergy Therapeutics plc
AGYTF
Price:
$0.11
Market Cap:
$487.00M
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-02-03
Stock Exchange
OTC
Ticker
AGYTF
PE Ratio
[-11.00]
ROE
[2.07%]
Current Ratio
[1.60]
Dividend Yield
[0%]
Enterprise Value
[509.84M]
Dividend History
The ROE as of December 2025 (TTM) for Allergy Therapeutics plc (AGYTF) is 2.07%
According to Allergy Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is 2.07%. This represents a change of -470.10% compared to the average of -559.86% of the last 4 quarters.
Allergy Therapeutics plc (AGYTF) Historical ROE (quarterly & annually)
How has AGYTF ROE performed in the past?
The mean historical ROE of Allergy Therapeutics plc over the last ten years is -325.80%. The current 2.07% ROE has changed -736.00% with respect to the historical average. Over the past ten years (40 quarters), AGYTF's ROE was at its highest in in the December 2024 quarter at 155.03%. The ROE was at its lowest in in the June 2023 quarter at -1673.04%.
Average
-325.80%
Median
-20.49%
Minimum
-2084.75%
Maximum
16.12%
Allergy Therapeutics plc (AGYTF) ROE by Quarter and Year
Discovering the peaks and valleys of Allergy Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.62%
Maximum Annual ROE = 16.12%
Minimum Annual Increase = -13858.16%
Minimum Annual ROE = -2084.75%
| Year | ROE | Change |
|---|---|---|
| 2024 | -1084.28% | -47.99% |
| 2023 | -2084.75% | 5.62% |
| 2022 | -36.48% | -713.47% |
| 2021 | 5.95% | -63.11% |
| 2020 | 16.12% | 74.63% |
| 2019 | 9.23% | -128.23% |
| 2018 | -32.70% | 294.99% |
| 2017 | -8.28% | -80.79% |
| 2016 | -43.11% | -13858.16% |
| 2015 | 0.31% | -93.63% |
Allergy Therapeutics plc (AGYTF) Average ROE
How has AGYTF ROE performed in the past?
The current ROE of Allergy Therapeutics plc (AGYTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1068.50%
5-year avg
-636.69%
10-year avg
-325.80%
Allergy Therapeutics plc (AGYTF) ROE vs. Peers
How is AGYTF’s ROE compared to its peers?
Allergy Therapeutics plc’s ROE is greater than Verano Holdings Corp. (-29.26%), greater than Glass House Brands Inc. (6.09%), less than ManifestSeven Holdings Corporation (1.66%), greater than Cresco Labs Inc. (-9.94%), greater than Boiron S.A. (5.18%), greater than JCR Pharmaceuticals Co., Ltd. (-10.87%), less than MedinCell S.A. (64.48%), greater than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (5.62%), less than Hua Medicine (Shanghai) Ltd. (232.98%), less than Lattice Biologics Ltd. (23.33%),
| Company | ROE | Market cap |
|---|---|---|
| -29.26% | $323.07M | |
| 6.09% | $491.26M | |
| 1.66% | $1.71K | |
| -9.94% | $300.34M | |
| 5.18% | $520.87M | |
| -10.87% | $548.93M | |
| 64.48% | $230.71M | |
| 5.62% | $643.13M | |
| 232.98% | $403.79M | |
| 23.33% | $16.55K |
Build a custom stock screener for Allergy Therapeutics plc (AGYTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allergy Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Allergy Therapeutics plc (AGYTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Allergy Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Allergy Therapeutics plc's ROE?
How is the ROE calculated for Allergy Therapeutics plc (AGYTF)?
What is the highest ROE for Allergy Therapeutics plc (AGYTF)?
What is the 3-year average ROE for Allergy Therapeutics plc (AGYTF)?
What is the 5-year average ROE for Allergy Therapeutics plc (AGYTF)?
How does the current ROE for Allergy Therapeutics plc (AGYTF) compare to its historical average?